HHS Nominee Pledges To Protect FDA “Brand”; Commissioner Coming Soon
Executive Summary
Upholding the trustworthiness of the FDA "brand" will be one of Michael Leavitt's priorities as HHS Secretary, the nominee said during his Jan. 18 confirmation hearing before the Senate Health Committee
You may also be interested in...
Canada-Only Import Plan “Feasible,” HHS Says: Savings Would Be “Modest”
The Bush Administration would accept a Canada-only importation program that focuses solely on high volume brands, HHS Secretary Thompson and Commerce Secretary Donald Evans indicated in a Dec. 21 letter to Congress
HHS Nominee Leavitt Leaves Medicare Rx Implementation Team Intact
President Bush's nomination of Michael Leavitt to head HHS will allow implementation of the Medicare prescription drug benefit to continue without distractions
Senate Drug Import Bill Would Require Notice Of Manufacturing Changes
Drug manufacturers would be required to notify FDA of any manufacturing changes that might serve to circumvent reimportation under bipartisan legislation introduced by Sens. Byron Dorgan (D-N.D.) and Edward Kennedy (D-Mass.) April 21